Related content

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children

By Qadri F.   Wenneras C.   Ahmed F.   Asaduzzaman M.   Saha D.   Albert M.J.   Sack R.B.   Svennerholm A.-M.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2704-2712

Elsevier

Access to resources Recommend Favorite

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

By Begue R.E.   Castellares G.   Ruiz R.   Hayashi K.E.   Sanchez J.L.   Gotuzzo E.   Oberst R.B.   Taylor D.N.   Svennerholm A.-M.  

Vaccine, Vol. 13, Iss. 7, 1995-01 ,pp. : 691-694

Elsevier

Access to resources Recommend Favorite

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

By Jertborn M.   Svennerholm A.-M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1459-1465

Elsevier

Access to resources Recommend Favorite

A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin

By Berstad A.K.H.   Holst J.   Mogster B.   Haugen I.L.   Haneberg B.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1473-1478

Elsevier

Access to resources Recommend Favorite

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite